LU82623A1 - Procede pour la preparation de matieres biocompatibles par l'immobilisation superficielle de l'apyrase,et articles fabriques obtenus par ce procede - Google Patents
Procede pour la preparation de matieres biocompatibles par l'immobilisation superficielle de l'apyrase,et articles fabriques obtenus par ce procede Download PDFInfo
- Publication number
- LU82623A1 LU82623A1 LU82623A LU82623A LU82623A1 LU 82623 A1 LU82623 A1 LU 82623A1 LU 82623 A LU82623 A LU 82623A LU 82623 A LU82623 A LU 82623A LU 82623 A1 LU82623 A1 LU 82623A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- apyrase
- rings
- biological agent
- support
- preparation
- Prior art date
Links
- 102000007347 Apyrase Human genes 0.000 title claims description 25
- 108010007730 Apyrase Proteins 0.000 title claims description 25
- 238000000034 method Methods 0.000 title claims description 23
- 238000002360 preparation method Methods 0.000 title claims description 4
- 239000000560 biocompatible material Substances 0.000 title claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229920000728 polyester Polymers 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 239000004953 Aliphatic polyamide Substances 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 229920003231 aliphatic polyamide Polymers 0.000 claims description 3
- 239000004760 aramid Substances 0.000 claims description 3
- 229920003235 aromatic polyamide Polymers 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 239000003124 biologic agent Substances 0.000 claims 5
- 239000012528 membrane Substances 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 12
- 229910019142 PO4 Inorganic materials 0.000 description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 description 11
- 239000011707 mineral Substances 0.000 description 11
- 235000021317 phosphate Nutrition 0.000 description 11
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 7
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 7
- 239000004677 Nylon Substances 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 229920001778 nylon Polymers 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 210000003191 femoral vein Anatomy 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- -1 Polyethylene terephthalate rings Polymers 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GDTSJMKGXGJFGQ-UHFFFAOYSA-N 3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical class O1B([O-])OB2OB([O-])OB1O2 GDTSJMKGXGJFGQ-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0047—Enzymes, e.g. urokinase, streptokinase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Surgery (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT24838/79A IT1122388B (it) | 1979-08-01 | 1979-08-01 | Procedimento per la preparazione di materiali biocompatibili tramite l'immobilizzazione superficiale di apirasi |
| IT2483879 | 1979-08-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU82623A1 true LU82623A1 (fr) | 1981-02-02 |
Family
ID=11214891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU82623A LU82623A1 (fr) | 1979-08-01 | 1980-07-14 | Procede pour la preparation de matieres biocompatibles par l'immobilisation superficielle de l'apyrase,et articles fabriques obtenus par ce procede |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4396716A (da) |
| JP (1) | JPS5672868A (da) |
| AT (1) | AT387906B (da) |
| AU (1) | AU536483B2 (da) |
| BE (1) | BE884301A (da) |
| BR (1) | BR8004430A (da) |
| CA (1) | CA1148466A (da) |
| CH (1) | CH645920A5 (da) |
| DE (1) | DE3026805A1 (da) |
| DK (1) | DK157887C (da) |
| ES (1) | ES493749A0 (da) |
| FI (1) | FI75737C (da) |
| FR (1) | FR2462475A1 (da) |
| GB (1) | GB2055848B (da) |
| IE (1) | IE49853B1 (da) |
| IT (1) | IT1122388B (da) |
| LU (1) | LU82623A1 (da) |
| NL (1) | NL190694C (da) |
| NO (1) | NO159607C (da) |
| SE (1) | SE448820B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3249491T1 (de) * | 1982-05-31 | 1984-04-19 | Mochida Pharmaceutical Co., Ltd., Tokyo | Immobilisiertes Pepsin zur Verwendung beim Entfernen von Immunkomplex aus dem Blut und eine Verfahren zur Entfernung von Immunkomplex aus dem Blut unter Verwendung des immobilisierten Pepsins |
| IT1208326B (it) * | 1984-03-16 | 1989-06-12 | Sorin Biomedica Spa | Protesi valvolare cardiaca provvista di lembi valvolari di tessuto biologico |
| US4838888A (en) * | 1987-04-17 | 1989-06-13 | Baxter Travenol Laboratories, Inc. | Calcification mitigation of implantable bioprostheses |
| JPH06508780A (ja) * | 1991-07-11 | 1994-10-06 | ビーティージー・インターナショナル・リミテッド | 移植片材料 |
| US5674725A (en) * | 1991-07-11 | 1997-10-07 | British Technology Group Limited | Implant materials having a phosphatase and an organophosphorus compound for in vivo mineralization of bone |
| US5378601A (en) * | 1992-07-24 | 1995-01-03 | Montefiore Medical Center | Method of preserving platelets with apyrase and an antioxidant |
| US5782931A (en) * | 1996-07-30 | 1998-07-21 | Baxter International Inc. | Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods |
| US20030232390A1 (en) * | 2002-03-15 | 2003-12-18 | Universal Bio Research Co., Ltd. | Carrier for fixing material containing amino group |
| US8628953B2 (en) * | 2007-11-29 | 2014-01-14 | Hitachi Plant Technologies, Ltd. | Capturing carrier, capturing device, analysis system using the same, and method for capturing and testing microorganisms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3865915A (en) * | 1969-09-15 | 1975-02-11 | Ici Ltd | Injection moulding of complex shaped laminar articles |
| US3705084A (en) * | 1970-03-18 | 1972-12-05 | Monsanto Co | Macroporous enzyme reactor |
| US3826678A (en) * | 1972-06-06 | 1974-07-30 | Atomic Energy Commission | Method for preparation of biocompatible and biofunctional materials and product thereof |
| US4273873A (en) * | 1977-10-25 | 1981-06-16 | Unitika Ltd. | Preparation of antithrombogenic polymeric materials |
-
1979
- 1979-08-01 IT IT24838/79A patent/IT1122388B/it active
-
1980
- 1980-07-02 AU AU60049/80A patent/AU536483B2/en not_active Ceased
- 1980-07-07 GB GB8022199A patent/GB2055848B/en not_active Expired
- 1980-07-08 NO NO802049A patent/NO159607C/no unknown
- 1980-07-08 DK DK294280A patent/DK157887C/da active
- 1980-07-09 SE SE8005061A patent/SE448820B/sv not_active IP Right Cessation
- 1980-07-09 CA CA000355799A patent/CA1148466A/en not_active Expired
- 1980-07-10 ES ES493749A patent/ES493749A0/es active Granted
- 1980-07-11 FR FR8015513A patent/FR2462475A1/fr active Granted
- 1980-07-14 LU LU82623A patent/LU82623A1/fr unknown
- 1980-07-14 BE BE0/201398A patent/BE884301A/fr not_active IP Right Cessation
- 1980-07-14 CH CH539180A patent/CH645920A5/it not_active IP Right Cessation
- 1980-07-14 IE IE1466/80A patent/IE49853B1/en not_active IP Right Cessation
- 1980-07-15 NL NL8004068A patent/NL190694C/xx not_active IP Right Cessation
- 1980-07-15 DE DE19803026805 patent/DE3026805A1/de active Granted
- 1980-07-15 BR BR8004430A patent/BR8004430A/pt unknown
- 1980-07-15 FI FI802246A patent/FI75737C/fi not_active IP Right Cessation
- 1980-07-15 JP JP9577780A patent/JPS5672868A/ja active Granted
- 1980-07-15 AT AT0367580A patent/AT387906B/de not_active IP Right Cessation
-
1981
- 1981-12-28 US US06/334,907 patent/US4396716A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5840190A (en) | Surface modified biocompatible membranes | |
| Larm et al. | A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue | |
| EP0397130B1 (en) | Medical device having highly biocompatible surface and method for manufacturing the same | |
| CA2270789C (fr) | Procede de preparation d'une colle biologique capable de coaguler par simple addition d'ions calcium | |
| LU82623A1 (fr) | Procede pour la preparation de matieres biocompatibles par l'immobilisation superficielle de l'apyrase,et articles fabriques obtenus par ce procede | |
| EP0902893A1 (fr) | Moyens pour la bio-epuration d'un fluide biologique | |
| FR2645870A1 (fr) | Procede de reticulation du collagene par le diphenylphosphorylazide, collagene reticule ainsi obtenu et biomateriaux a base de collagene ainsi reticules | |
| Raghunath et al. | Some characteristics of collagen‐heparin complex | |
| JP2003504622A (ja) | 親水性マトリックス材料を含んでなるセンサー | |
| US7223532B1 (en) | Blood compatible polymer surfaces | |
| EP1622596B1 (fr) | Implant injectable de globine insoluble | |
| FR2554349A1 (fr) | Procede d'obtention de materiaux biocompatibles, materiaux obtenus par ce procede et leurs applications | |
| Marconi | New nonthrombogenic polymer compositions | |
| Kálal | Interaction of synthetic polymers with components of the living materials | |
| RU2699045C1 (ru) | Способ модификации поверхности биоразлагаемых полимерных материалов | |
| RU2388495C1 (ru) | Способ получения тромборезистентных полимерных материалов | |
| RU2155593C2 (ru) | Способ формирования гепаринизированной поверхности | |
| JPH01118530A (ja) | フィブロイン成形物およびその製造方法 | |
| JPH0811130B2 (ja) | 腎臓透析膜、血漿分離膜、ゾンデ、血漿浄化基材の如き抗炎症性で医療用、または外科用の不溶性物品 | |
| FR2872821A1 (fr) | Colle lyophilisee a base de collagene et son utilisation pour la fabrication de protheses collantes | |
| JPH11276574A (ja) | 抗血栓性医療用具 | |
| CN107496991A (zh) | 一种使人造血管的持久保持通畅的试剂盒和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DT | Application date | ||
| TA | Annual fee |